20/20 Biolabs furnishes investor presentation for July 1 webinar; no material new information disclosed

20/20 Biolabs, Inc.

Presentation furnished as Exhibit 99.1 for Regulation FD purposes.
No specific financial or operational data provided in the filing.
Company intends to use materials in investor webinar on July 1, 2026.

item 7.01 item 9.01

20/20 Biolabs, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-26-074182

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.